MADISON, Wis. (AP) — MADISON, Wis. (AP) — Exact Sciences Corp. (EXAS) on Tuesday reported a loss of $81 million in its second quarter.
On a per-share basis, the Madison, Wisconsin-based company said it had a loss of 45 cents.
The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 50 cents per share.
The molecular diagnostics company posted revenue of $622.1 million in the period, also topping Street forecasts. Eight analysts surveyed by Zacks expected $599 million.
Exact Sciences expects full-year revenue in the range of $2.44 billion to $2.47 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EXAS at https://www.zacks.com/ap/EXAS
/Amazon%20-%20Image%20by%20bluestork%20via%20Shutterstock.jpg)
/Apple%20Inc%20logo%20on%20Apple%20store-by%20PhillDanze%20via%20iStock.jpg)
/Space%20Technology%20by%20Rini_%20com%20via%20Shutterstock.jpg)